Cargando…

Genome-editing tools for stem cell biology

Human pluripotent stem cells provide a versatile platform for regenerative studies, drug testing and disease modeling. That the expression of only four transcription factors, Oct4, Klf4, Sox2 and c-Myc (OKSM), is sufficient for generation of induced pluripotent stem cells (iPSCs) from differentiated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasileva, E A, Shuvalov, O U, Garabadgiu, A V, Melino, G, Barlev, N A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650720/ https://www.ncbi.nlm.nih.gov/pubmed/26203860 http://dx.doi.org/10.1038/cddis.2015.167

Ejemplares similares

Lysine-specific modifications of p53: a matter of life and death?
por: Marouco, Diana, et al.
Publicado: (2013)

KMT Set7/9 affects genotoxic stress response via the Mdm2 axis
por: Lezina, Larissa, et al.
Publicado: (2015)

The 2nd International Workshop ‘Novel Therapeutic Strategies in Cancer' in St-Petersburg
por: Tentler, D, et al.
Publicado: (2013)

The Role of Lysine Methyltransferase SET7/9 in Proliferation and Cell Stress Response
por: Daks, Alexandra, et al.
Publicado: (2022)

miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress
por: Lezina, L, et al.
Publicado: (2013)

MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets
por: Antonov, A V, et al.
Publicado: (2013)

The biological basis and clinical symptoms of CAR-T therapy-associated toxicites
por: Titov, Aleksei, et al.
Publicado: (2018)

One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy
por: Shuvalov, Oleg, et al.
Publicado: (2017)

E3 ubiquitin ligase Pirh2 enhances tumorigenic properties of human non-small cell lung carcinoma cells
por: Daks, Alexandra, et al.
Publicado: (2016)

Genome editing: from tools to biological insights
por: Yao, Yixin
Publicado: (2018)

An Arthropod Hormone, Ecdysterone, Inhibits the Growth of Breast Cancer Cells via Different Mechanisms
por: Shuvalov, O., et al.
Publicado: (2020)

Genome Editing and Muscle Stem Cells as a Therapeutic Tool for Muscular Dystrophies
por: Pini, Veronica, et al.
Publicado: (2017)

Caspase-1 is a novel target of p63 in tumor suppression
por: Celardo, I, et al.
Publicado: (2013)

Emerging Species and Genome Editing Tools: Future Prospects in Cyanobacterial Synthetic Biology
por: Gale, Grant A. R., et al.
Publicado: (2019)

Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing tools
por: Teo, Adrian Kee Keong, et al.
Publicado: (2015)

Genome Editing Tools in Plants
por: Mohanta, Tapan Kumar, et al.
Publicado: (2017)

Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology
por: Beer, Nicola L., et al.
Publicado: (2016)

Genome editing is revolutionizing biology
por: Qi, Yiping
Publicado: (2017)

Genome Editing for Plasmodesmal Biology
por: Iswanto, Arya Bagus Boedi, et al.
Publicado: (2021)

Probing the impact of chromatin conformation on genome editing tools
por: Chen, Xiaoyu, et al.
Publicado: (2016)

Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition
por: Semenov, Oleg, et al.
Publicado: (2022)

The Role of PTEN in Epithelial–Mesenchymal Transition
por: Fedorova, Olga, et al.
Publicado: (2022)

The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase
por: Daks, Alexandra, et al.
Publicado: (2021)

DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity
por: Moiseeva, Tatiana N., et al.
Publicado: (2013)

Rapamycin regulates biochemical metabolites
por: Tucci, Paola, et al.
Publicado: (2013)

Computational Tools and Resources for CRISPR/Cas Genome Editing
por: Li, Chao, et al.
Publicado: (2023)

Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells
por: Shuvalov, Oleg, et al.
Publicado: (2021)

Genome Editing in Medicine: Tools and Challenges
por: Petraitytė, Gunda, et al.
Publicado: (2021)

The 26S proteasome is a multifaceted target for anti-cancer therapies
por: Grigoreva, Tatyana A, et al.
Publicado: (2015)

Delivery of genome editing tools by bacterial extracellular vesicles
por: Liu, Yue, et al.
Publicado: (2018)

Linking Metabolic Reprogramming, Plasticity and Tumor Progression
por: Shuvalov, Oleg, et al.
Publicado: (2021)

How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?
por: Kirdeeva, Yulia, et al.
Publicado: (2022)

The Role of E3 Ligase Pirh2 in Disease
por: Daks, Alexandra, et al.
Publicado: (2022)

CRISPR/Cas9 system: a reliable and facile genome editing tool in modern biology
por: Javaid, Darakhshan, et al.
Publicado: (2022)

TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery
por: Nemudryi, A. A., et al.
Publicado: (2014)

Evaluation of genome and base editing tools in maize protoplasts
por: Fierlej, Yannick, et al.
Publicado: (2022)

The CRISPR tool kit for genome editing and beyond
por: Adli, Mazhar
Publicado: (2018)

Points of View on the Tools for Genome/Gene Editing
por: Chuang, Chin-Kai, et al.
Publicado: (2021)

Optimization of scarless human stem cell genome editing
por: Yang, Luhan, et al.
Publicado: (2013)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
por: Shui, Bing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bubl36at41sg8kk4t8ddmr5sr1